The p53 tumor suppressor gene continues to hold distinction as the most frequently mutated gene in human cancer. The powerful selection for mutation of p53 in cancer is believed to result from its ability to induce programmed cell death (apoptosis). Evidence from several groups indicates that apoptosis induction by p53 does not rely on its best- characterized activity, transcriptional activation. This proposal seeks to characterize a new activity of p53, sequence-specific transcriptional repression. Wild type (wt) p53 induction in normal and tumor cells leads to transcriptional repression of Map4, which encodes a ubiquitously- expressed microtubule-polymerizing protein. Overexpression of Map4 in cells undergoing p53-dependent apoptosis delays the appearance of dying cells, verifying the importance of this process to apoptosis. In stably- transfected cells, the Map4 promoter can confer negative regulation by p53 to a heterologous gene. A fragment of this promoter can interact with wt but not mutant p53 protein in cell extracts. Recent data indicate that in addition to Map4, p53 represses other genes encoding components of microtubules. Elucidation of the mechanism of transcriptional repression by p53 is likely to be a critical step toward understanding tumor suppression by this protein. Understanding other targets genes of p53-mediated repression will also be important. This proposal seeks to achieve these goals.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA080854-04
Application #
6497532
Study Section
Pathology B Study Section (PTHB)
Program Officer
Blair, Donald G
Project Start
1999-04-01
Project End
2004-01-31
Budget Start
2002-02-01
Budget End
2003-01-31
Support Year
4
Fiscal Year
2002
Total Cost
$258,605
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Pimkina, Julia; Humbey, Olivier; Zilfou, Jack T et al. (2009) ARF induces autophagy by virtue of interaction with Bcl-xl. J Biol Chem 284:2803-10
Pimkina, Julia; Murphy, Maureen E (2009) ARF, autophagy and tumor suppression. Autophagy 5:397-9
Humbey, Olivier; Pimkina, Julia; Zilfou, Jack T et al. (2008) The ARF tumor suppressor can promote the progression of some tumors. Cancer Res 68:9608-13
Pietsch, E Christine; Murphy, Maureen E (2008) Low risk HPV-E6 traps p53 in the cytoplasm and induces p53-dependent apoptosis. Cancer Biol Ther 7:1916-8
Pietsch, E C; Sykes, S M; McMahon, S B et al. (2008) The p53 family and programmed cell death. Oncogene 27:6507-21
Murphy, Maureen E; Leu, J I-Ju; George, Donna L (2004) p53 moves to mitochondria: a turn on the path to apoptosis. Cell Cycle 3:836-9
Leu, J I-Ju; Dumont, Patrick; Hafey, Michael et al. (2004) Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 6:443-50
Hoffman, William H; Biade, Siham; Zilfou, Jack T et al. (2002) Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277:3247-57
Zilfou, J T; Hoffman, W H; Sank, M et al. (2001) The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation. Mol Cell Biol 21:3974-85
Murphy, M; Ahn, J; Walker, K K et al. (1999) Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev 13:2490-501